Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly

Increasingly, clinical trials for Alzheimer’s disease (AD) are being conducted earlier in the disease phase and with biomarker confirmation using in vivo amyloid PET imaging or CSF tau and Aβ measures to quantify pathology. However, making such a pre-clinical AD diagnosis is relatively costly and th...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Alzheimers Dis
Prif Awduron: Westwood, Sarah, Leoni, Emanuela, Hye, Abdul, Lynham, Steven, Khondoker, Mizanur R., Ashton, Nicholas J., Kiddle, Steven J., Baird, Alison L., Sainz-Fuertes, Ricardo, Leung, Rufina, Graf, John, Hehir, Cristina Tan, Baker, David, Cereda, Cristina, Bazenet, Chantal, Ward, Malcolm, Thambisetty, Madhav, Lovestone, Simon
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2016
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5898378/
https://ncbi.nlm.nih.gov/pubmed/27031486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-151155
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg